Emasan AG is offering around 26.5M shares in Swiss Novartis (NVS) through Goldman Sachs, potentially raising $3B, Pablo Mayo Cerqueiro of Bloomberg reports, citing terms of the share sale. Emasan is selling a 1.2% stake through an accelerated placement with investors, according to Bloomberg. Shares of Novartis moved lower following the report but remain up 2% to $111.01 in midday trading.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Emasan files to sell 26.5M shares of Novartis, Bloomberg reports
- Amgen (NASDAQ:AMGN) to Invest $200M in India High Tech Site as Trump Tariffs Loom
- Novartis’ Ianalumab granted FDA orphan designation
- Novartis downgraded to Neutral from Buy at UBS
- Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?